Mayo Clinic Covid-19 Research Task Force chair Dr. Andrew Badley on discontinuing the use of hydroxychloroquine to treat coronavirus and how the side effects outweigh any benefits.
Coronavirus patients treated with hydroxychloroquine (HCQ), as well as a combination of the malaria drug with an antibiotic, had higher survival rates than those who were not treated with the drug, a new study has found.
Researchers at Henry Ford Hospital in Detroit saw a "significant reduction" in mortality rates with patients who were hospitalized between March 10 and May 2 and treated with the drug compared to those who were not. Hydroxychloroquine has been a topic of controversy since President Trump touted its effectiveness as early as March. The president also said he had been taking the drug.
"The results of this study demonstrate that in a strictly monitored protocol-driven in-hospital setting, treatment with hydroxychloroquine alone and hydroxychloroquine [and] azithromycin was associated with a significant reduction in mortality among patients hospitalized with COVID-19," researchers wrote in the study published July 1 in the International Journal of Infectious Diseases.